| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-23 | Kim Hanjoon Alex | officer | F | 202,476 | $0.90 | $181K |
| 2026-04-06 | Kim Hanjoon Alex | officer | Option exercise | 70,183 | — | — |
| 2026-04-06 | Kim Hanjoon Alex | officer | F | 21,301 | $0.91 | $19K |
| 2026-04-06 | Kim Hanjoon Alex | officer | Option exercise | 70,183 | — | — |
| 2026-04-06 | Egholm Michael | director, officer | Option exercise | 196,513 | — | — |
| 2026-04-06 | Egholm Michael | director, officer | F | 95,014 | $0.91 | $86K |
| 2026-04-06 | Egholm Michael | director, officer | Option exercise | 196,513 | — | — |
| 2026-03-20 | Egholm Michael | director, officer | Award | 1,042,373 | — | — |
| 2026-03-20 | Mackay Sean | officer | Award | 272,107 | — | — |
| 2026-03-20 | Kim Hanjoon Alex | officer | Award | 323,173 | — | — |
| 2026-03-20 | Kim Hanjoon Alex | officer | Award | 727,140 | $0.98 | $716K |
| 2026-03-20 | Mackay Sean | officer | Award | 612,240 | $0.98 | $603K |
| 2026-03-20 | Egholm Michael | director, officer | Award | 2,345,340 | $0.98 | $2.31M |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-06-12 | SCHEDULE 13D | VIKING GLOBAL INVESTORS LP | 15.00% | 58,651,170 | view → |
| 2026-06-09 | SCHEDULE 13D/A | Casdin Capital, LLC | 23.90% | 88,783,856 | view → |
| 2025-03-04 | SCHEDULE | Casdin Capital, LLC | 21.60% | 80,864,315 | view → |
| 2024-01-08 | SC | Caligan Partners LP | — | — | view → |
| 2023-07-03 | SC | Caligan Partners LP | — | — | view → |
| 2022-08-05 | SC | Caligan Partners LP | — | — | view → |
| 2019-04-02 | SC | LEVIN CAPITAL STRATEGIES, L.P. | — | — | view → |
| 2019-03-20 | SC | LEVIN CAPITAL STRATEGIES, L.P. | — | — | view → |
| 2018-03-06 | SC | LEVIN CAPITAL STRATEGIES, L.P. | — | — | view → |
| 2018-01-11 | SC | LEVIN CAPITAL STRATEGIES, L.P. | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-06-09 | SCHEDULE 13D/A | Standard BioTools Inc. LAB | 23.90% | 88,783,856 | view → |
| 2026-06-04 | SCHEDULE 13G | BIOLIFE SOLUTIONS INC BLFS | — | — | view → |
| 2026-05-22 | SCHEDULE 13D/A | BIOLIFE SOLUTIONS INC BLFS | 9.70% | 4,757,165 | view → |
| 2025-08-13 | SCHEDULE | BIOLIFE SOLUTIONS INC BLFS | 15.00% | 7,207,165 | view → |
| 2025-03-07 | SCHEDULE | Tenaya Therapeutics, Inc. TNYA | 4.30% | 6,732,971 | view → |
| 2025-03-04 | SCHEDULE | STANDARD BIOTOOLS INC. LAB | 21.60% | 80,864,315 | view → |
| 2023-03-20 | SC | Absci Corp ABSI | — | — | view → |
| 2022-11-28 | SC | Tenaya Therapeutics, Inc. TNYA | — | — | view → |
| 2022-10-11 | SC | Century Therapeutics, Inc. IPSC | — | — | view → |
| 2020-05-18 | SC | GenMark Diagnostics, Inc. | — | — | view → |
| 2020-02-07 | SC | GenMark Diagnostics, Inc. | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →